Mercator MedSystems
Organisation
People
President/chief science & tech officer
Sources: reporter.nih.gov
Trials
Phase 2, Status unknown, 120 people, 24 Jun 2015
Phase 2, Status unknown, 120 people, 24 Jun 2015
Phase 4, Completed, 285 people, 14 Nov 2013
Grants and prizes
National Heart, Lung, and Blood Institute
R44, Improved Sirolimus-Analog Adventitial Delivery to Enhance Outcomes in Below-the-Knee Peripheral Artery Disease, R44HL102998, US$1m, 2010–2026, 11 May 2026
Sources: reporter.nih.gov